David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Boise Cascade
BCC
$2.83B
| $786K | ﹤0.01% |
19,700
-14,138
| -42% | -$524K |
|
2677
Enanta Pharmaceuticals
ENTA
$410M
| $785K | ﹤0.01% |
13,374
-6,258
| -32% | -$313K |
|
2678
National Bank Holdings
NBHC
$1.84B
| $785K | ﹤0.01% |
24,213
-347
| -1% | -$11.6K |
|
2679
Patrick Industries
PATK
$2.74B
| $785K | ﹤0.01% |
16,952
-7,672
| -31% | -$315K |
|
2680
CALL
Interactive Brokers
IBKR
$44.5B
| $782K | ﹤0.01% |
52,800
+19,200
| +57% | +$262K |
|
|
GPT
2681
DELISTED
Gramercy Property Trust
GPT
| $782K | ﹤0.01% |
29,335
+22,426
| +325% | +$651K |
|
2682
CALL
POSCO
PKX
$18B
| $781K | ﹤0.01% |
10,000
| – | – |
|
|
PAY
2683
PUT
DELISTED
Verifone Systems Inc
PAY
| $781K | ﹤0.01% |
44,100
+20,000
| +83% | +$372K |
|
2684
Invitation Homes
INVH
$17.9B
| $779K | ﹤0.01% |
33,064
-19,710
| -37% | -$456K |
|
|
VSI
2685
DELISTED
Vitamin Shoppe Inc.
VSI
| $778K | ﹤0.01% |
176,864
+94,234
| +114% | +$415K |
|
2686
Deere & Co
DE
$170B
| $775K | ﹤0.01% |
4,951
-127,154
| -96% | -$17.8M |
|
|
BRKL
2687
DELISTED
Brookline Bancorp
BRKL
| $771K | ﹤0.01% |
49,090
-74,472
| -60% | -$1.16M |
|
2688
CALL
Synaptics
SYNA
$3.71B
| $767K | ﹤0.01% |
19,200
+4,900
| +34% | +$187K |
|
2689
PUT
Cheesecake Factory
CAKE
$5.65B
| $766K | ﹤0.01% |
15,900
| – | – |
|
2690
Akebia Therapeutics
AKBA
$266M
| $764K | ﹤0.01% |
51,349
-48,588
| -49% | -$806K |
|
2691
Martin Marietta Materials
MLM
$37.8B
| $764K | ﹤0.01% |
3,458
-16,265
| -82% | -$3.41M |
|
2692
Celldex Therapeutics
CLDX
$3.24B
| $761K | ﹤0.01% |
17,849
+10,702
| +150% | +$458K |
|
2693
First Financial Bankshares
FFIN
$4.83B
| $759K | ﹤0.01% |
+33,682
| New | +$767K |
|
|
AFSI
2694
PUT
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $755K | ﹤0.01% |
+75,000
| New | +$850K |
|
2695
Cytokinetics
CYTK
$10.8B
| $752K | ﹤0.01% |
92,226
-53,440
| -37% | -$607K |
|
2696
Addus HomeCare
ADUS
$2.26B
| $750K | ﹤0.01% |
21,562
+698
| +3% | +$23.7K |
|
2697
StoneX
SNEX
$8.4B
| $749K | ﹤0.01% |
89,211
-59,191
| -40% | -$487K |
|
|
AIG.WS
2698
DELISTED
American International Group, Inc.
AIG.WS
| $748K | ﹤0.01% |
41,284
| – | – |
|
2699
PUT
Yelp
YELP
$1.29B
| $747K | ﹤0.01% |
17,800
| – | – |
|
2700
Sempra
SRE
$54.9B
| $746K | ﹤0.01% |
13,948
-12,682
| -48% | -$735K |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.